Is AOC1 rs10156191 TT linked to lower DAO activity and histamine-type symptoms?

Diamine oxidase (DAO), encoded by the AOC1 gene, is the primary extracellular enzyme responsible for degrading dietary histamine within the intestinal tract. When genetic variations compromise this pathway, undegraded histamine enters the systemic circulation, driving multi-organ reactivity.

Genetic and molecular mechanisms

• The AOC1 rs10156191 polymorphism is a missense C>T variant (c.47C>T) that leads to a threonine-to-methionine amino acid substitution at position 16 (Thr16Met).
• This structural alteration reduces the baseline core activity and intrinsic metabolic capacity of the DAO enzyme.
• Evidence demonstrates a clear gene-dosage effect: wild-type CC individuals have normal activity, heterozygous CT carriers show mild impairment, and homozygous TT carriers exhibit the most severe reduction in plasma DAO activity.

Clinical implications and symptoms

• Impaired intestinal DAO activity allows dietary histamine to cross the mucosal barrier undegraded, driving histamine intolerance.
• Systemic spillover of histamine triggers diverse clinical symptoms, including gastrointestinal issues (bloating, abdominal pain, food sensitivities) and cardiovascular effects (palpitations, tachycardia).
• The risk T allele is also clinically associated with increased migraine susceptibility—particularly in women—and crossed hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs).

Modifying factors and interventions

• Alcohol consumption directly inhibits DAO activity, further worsening histamine clearance and exacerbating symptoms.
• Clinical interventions such as a low-histamine diet and oral DAO supplementation effectively bypass endogenous genetic deficits, accelerating histamine breakdown in the gut lumen to reduce symptom frequency and severity.

Bottom line

• The homozygous AOC1 rs10156191 TT genotype causes a structural Thr16Met DAO enzyme deficiency, directly impairing intestinal histamine clearance and leading to systemic symptoms like bloating, food sensitivities, and palpitations.